Boron Neutron Capture Therapy (BNCT) Mediated by Maleimide-Functionalized Closo -Dodecaborate Albumin Conjugates (MID:BSA) for Oral Cancer: Biodistribution Studies and In Vivo BNCT in the Hamster Cheek Pouch Oral Cancer Model.
Andrea Monti HughesJessica A GoldfingerMónica A PalmieriPaula RamosIara S Santa CruzLuciana De LeoMarcela A GarabalinoSilvia I ThorpPaula CurottoEmiliano C C PozziKazuki KawaiShinichi SatoMaría E ItoizVerónica A TrivillinJuan S GuidobonoHiroyuki NakamuraAmanda Elena SchwintPublished in: Life (Basel, Switzerland) (2022)
MID:BSA/BNCT would be therapeutically useful to treat oral cancer. BSA toxicity is a consideration when injecting a compound conjugated to BSA and depends on the animal model studied.